Analysts Offer Insights on Healthcare Companies: SAGE Therapeutics (NASDAQ: SAGE) and Revolution Medicines (NASDAQ: RVMD)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on SAGE Therapeutics (SAGE – Research Report) and Revolution Medicines (RVMD – Research Report). SAGE Therapeutics (SAGE) In More »
JonesTrading Keeps Their Buy Rating on Chimerix (CMRX)
In a report released today, Soumit Roy from JonesTrading reiterated a Buy rating on Chimerix (CMRX – Research Report), with a price target of $14.00. The company’s shares closed last Friday at More »
-
Tech
-
A Major Shareholder at OneSpan (NASDAQ: OSPN) is Buying Shares
Today, a Major Shareholder at OneSpan (OSPN – Research Report), Kendall Hunt, bought shares of OSPN for $6.6M. Read More » -
Analysts Offer Insights on Technology Companies: Amdocs (NASDAQ: DOX), Rada Electronics (NASDAQ: RADA) and CrowdStrike Holdings (NASDAQ: CRWD)
There’s a lot to be optimistic about in the Technology sector as 3 analysts just weighed in on Read More »
-
-
Industrial Goods
-
Hardwoods Distribution (HDIUF) Receives a Buy from Canaccord Genuity
Canaccord Genuity analyst Yuri Lynk maintained a Buy rating on Hardwoods Distribution (HDIUF – Research Report) yesterday and Read More » -
Analysts Offer Insights on Conglomerates Companies: and International Seaways (NYSE: INSW)
There’s a lot to be optimistic about in the Conglomerates sector as 1 analysts just weighed in on Read More »
-
-
Financial
-
The Executive of Swiss Re AG is Exercising Options
Today it was reported that the Executive of Swiss Re AG (SSREF – Research Report), Unnamed Swiss Director Read More » -
The Chief Financial Officer of Nedbank Group is Exercising Options
Today it was reported that the Chief Financial Officer of Nedbank Group (NDBKF – Research Report), Mh Davis, Read More »
-
-
Healthcare
-
Gain Therapeutics (GANX) Has a New Rating from Oppenheimer
In a report released today, Hartaj Singh from Oppenheimer initiated coverage with a Buy rating on Gain Therapeutics Read More » -
H.C. Wainwright Remains a Buy on Fulcrum Therapeutics (FULC)
In a report released today, Andrew Fein from H.C. Wainwright reiterated a Buy rating on Fulcrum Therapeutics (FULC Read More »
-
-
Consumer Goods
-
The SVP – CAO & Controller of Michaels Companies is Exercising Options
Yesterday it was reported that the SVP – CAO & Controller of Michaels Companies (MIK – Research Report), Read More » -
Amazon (AMZN) Receives a New Rating from a Top Analyst
Needham analyst Laura Martin assigned a Buy rating to Amazon (AMZN – Research Report) today and set a Read More »
-
-
Services
-
A Director at Dave & Busters Entertainment (NASDAQ: PLAY) is Selling Shares
Yesterday, a Director at Dave & Busters Entertainment (PLAY – Research Report), Stephen King, sold shares of PLAY Read More » -
A Director at Monarch Casino & Resort (NASDAQ: MCRI) is Buying Shares
Today, a Director at Monarch Casino & Resort (MCRI – Research Report), Yvette Landau, bought shares of MCRI Read More »
-